
Treating gum disease can offer relief to men suffering from a prostate condition that makes urination difficult, reveals new research.
Gum disease treatment reduces symptoms of prostate inflammation, called prostatitis, a disease that inflames the gland that produces semen, the findings showed.
Advertisement
"This study shows that if we treat the gum disease, it can improve the symptoms of prostatitis and the quality of life for those who have the disease," said corresponding author Nabil Bissada from Case Western Reserve University School of Dental Medicine.
Bissada explained that gum disease not only affects the mouth, but is a system-wide condition that can cause inflammation in various parts of the body.
The researchers studied 27 men, 21 years old and older. Each had had a needle biopsy within the past year that confirmed inflammation of the prostate gland, and a blood test that showed elevated prostate specific antigen (PSA) levels--possible signs of inflammation and cancer.
Researchers found 21 of the 27 participants had no or mild inflammation, but 15 had biopsy-confirmed malignancies. Two had both inflammation and a malignancy.
All the men had moderate to severe gum disease, for which they received treatment. They were tested again for periodontal disease four to eight weeks later and showed significant improvement.
During the periodontal care, the men received no treatment for their prostate conditions. But even without prostate treatment, 21 of the 27 men showed decreased levels of PSA.
Those with the highest levels of inflammation benefited the most from the periodontal treatment. Six participants showed no changes.
Bissada hopes to make periodontal treatment a standard part of treating prostate disease, much like cardiac patients are often encouraged to visit their dentist before undergoing heart procedures and a dental checkup is advised for women who are pregnant or considering pregnancy.
The findings appeared in the journal Dentistry.
Source: IANS
Advertisement
The researchers studied 27 men, 21 years old and older. Each had had a needle biopsy within the past year that confirmed inflammation of the prostate gland, and a blood test that showed elevated prostate specific antigen (PSA) levels--possible signs of inflammation and cancer.
Researchers found 21 of the 27 participants had no or mild inflammation, but 15 had biopsy-confirmed malignancies. Two had both inflammation and a malignancy.
All the men had moderate to severe gum disease, for which they received treatment. They were tested again for periodontal disease four to eight weeks later and showed significant improvement.
During the periodontal care, the men received no treatment for their prostate conditions. But even without prostate treatment, 21 of the 27 men showed decreased levels of PSA.
Those with the highest levels of inflammation benefited the most from the periodontal treatment. Six participants showed no changes.
Bissada hopes to make periodontal treatment a standard part of treating prostate disease, much like cardiac patients are often encouraged to visit their dentist before undergoing heart procedures and a dental checkup is advised for women who are pregnant or considering pregnancy.
The findings appeared in the journal Dentistry.
Source: IANS
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Research News

Utilizing microparticles for therapy could mark a significant milestone in the fight against multiple sclerosis (MS) and other autoimmune diseases.

A study revealed that children with drug-resistant epilepsy (DRE) had the highest survival rate beyond 10 years when they underwent cranial epilepsy surgery.

From childhood through adolescence, the brain constantly changes, and researchers are making strides in identifying a potential treatment target for neuropsychiatric disorders.

In Japan, babies born in 2022 was also a record low at 770,747, down 40,875 from 2021, revealed data.

The first direct evidence supported the main theory for how human memory is amalgamated during sleep.